Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$1.59 – $2.43
14% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.49B | $2.35B | $1.91B | $2.18B | $2.44B | $2.40B | $2.28B | $2.30B |
| Cost of revenue | $1.24B | $1.26B | $948.4M | $1.14B | $1.26B | $1.25B | $1.15B | $1.92B |
| Gross profit | $1.25B | $1.09B | $988.2M | $1.04B | $1.17B | $1.15B | $1.13B | $384.5M |
| Gross margin | 50.2% | 46.4% | 51.7% | 47.6% | 48.1% | 47.9% | 49.6% | 16.7% |
| R&D | $127.0M | $126.0M | $87.0M | $98.0M | $96.0M | $104.0M | $0 | $0 |
| Operating income | $81.0M | −$269.4M | $17.6M | $80.7M | $131.0M | $91.0M | $61.0M | $67.3M |
| EBITDA | $163.7M | −$182.9M | $96.7M | $146.3M | $202.0M | $173.0M | $141.0M | $148.0M |
| Net income | $20.9M | −$343.0M | −$42.9M | $33.0M | $91.0M | $39.0M | $5.0M | $15.1M |
| Net margin | 0.8% | -14.6% | -2.2% | 1.5% | 3.7% | 1.6% | 0.2% | 0.7% |
| EPS (diluted) | 0.07 | -1.13 | -0.14 | 0.11 | 0.30 | 0.13 | 0.02 | 0.05 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $2.3B | $0.11 | $0.11–$0.11 | 1 |
| 2028 | $2.4B | $0.17 | $0.16–$0.17 | 1 |
| 2029 | $2.4B | $0.22 | $0.22–$0.23 | 1 |
Forward consensus · source: Financial Modeling Prep
HEIDELBERGER DRUCK
No one on the platform currently holds HBGRF.
No tracked institution reports a position in HBGRF as of their last filing.
No one on the platform has traded HBGRF yet.
| $662M |
| — |
| NLLSFNel ASA | $0.25 | +3.39% | $455M | — |
| NLLSYNel ASA | $7.67 | -1.16% | $470M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 73.9× earnings vs its 22.0× historical median P/E.
Fair value ≈ $0.51 · price $1.70 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.